These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 19941471)

  • 1. Thioredoxin system modulation by plant and fungal secondary metabolites.
    Dal Piaz F; Braca A; Belisario MA; De Tommasi N
    Curr Med Chem; 2010; 17(5):479-94. PubMed ID: 19941471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting the Thioredoxin System for Cancer Therapy.
    Zhang J; Li X; Han X; Liu R; Fang J
    Trends Pharmacol Sci; 2017 Sep; 38(9):794-808. PubMed ID: 28648527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The thioredoxin antioxidant system.
    Lu J; Holmgren A
    Free Radic Biol Med; 2014 Jan; 66():75-87. PubMed ID: 23899494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thioredoxin system inhibitors as mediators of apoptosis for cancer therapy.
    Tonissen KF; Di Trapani G
    Mol Nutr Food Res; 2009 Jan; 53(1):87-103. PubMed ID: 18979503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacterial thioredoxin and thioredoxin reductase as mediators for epigallocatechin 3-gallate-induced antimicrobial action.
    Liang W; Fernandes AP; Holmgren A; Li X; Zhong L
    FEBS J; 2016 Feb; 283(3):446-58. PubMed ID: 26546231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The thioredoxin reductase/thioredoxin system: novel redox targets for cancer therapy.
    Biaglow JE; Miller RA
    Cancer Biol Ther; 2005 Jan; 4(1):6-13. PubMed ID: 15684606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A thioredoxin reductase and/or thioredoxin system-based mechanism for antioxidant effects of ambroxol.
    Huang J; Xu J; Tian L; Zhong L
    Biochimie; 2014 Feb; 97():92-103. PubMed ID: 24103200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in the development of thioredoxin reductase inhibitors as anticancer agents.
    Liu Y; Li Y; Yu S; Zhao G
    Curr Drug Targets; 2012 Oct; 13(11):1432-44. PubMed ID: 22876886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The thioredoxin system and cancer therapy: a review.
    Mohammadi F; Soltani A; Ghahremanloo A; Javid H; Hashemy SI
    Cancer Chemother Pharmacol; 2019 Nov; 84(5):925-935. PubMed ID: 31367788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of the inhibition of mammalian thioredoxin, thioredoxin reductase, and glutaredoxin by cis-diamminedichloroplatinum (II) and its major metabolite, the glutathione-platinum complex.
    Arnér ES; Nakamura H; Sasada T; Yodoi J; Holmgren A; Spyrou G
    Free Radic Biol Med; 2001 Nov; 31(10):1170-8. PubMed ID: 11705695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of Mammalian thioredoxin reductase by some flavonoids: implications for myricetin and quercetin anticancer activity.
    Lu J; Papp LV; Fang J; Rodriguez-Nieto S; Zhivotovsky B; Holmgren A
    Cancer Res; 2006 Apr; 66(8):4410-8. PubMed ID: 16618767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting the Thioredoxin Reductase-Thioredoxin System from Staphylococcus aureus by Silver Ions.
    Liao X; Yang F; Li H; So PK; Yao Z; Xia W; Sun H
    Inorg Chem; 2017 Dec; 56(24):14823-14830. PubMed ID: 29182243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thioredoxin system in cell death progression.
    Lu J; Holmgren A
    Antioxid Redox Signal; 2012 Dec; 17(12):1738-47. PubMed ID: 22530689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Photoactive Platinum(IV) Anticancer Complex Inhibits Thioredoxin-Thioredoxin Reductase System Activity by Induced Oxidization of the Protein.
    Du J; Wei Y; Zhao Y; Xu F; Wang Y; Zheng W; Luo Q; Wang M; Wang F
    Inorg Chem; 2018 May; 57(9):5575-5584. PubMed ID: 29688719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thioredoxin Cross-Linking by Nitrogen Mustard in Lung Epithelial Cells: Formation of Multimeric Thioredoxin/Thioredoxin Reductase Complexes and Inhibition of Disulfide Reduction.
    Jan YH; Heck DE; Casillas RP; Laskin DL; Laskin JD
    Chem Res Toxicol; 2015 Nov; 28(11):2091-103. PubMed ID: 26451472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular bases of thioredoxin and thioredoxin reductase-mediated prooxidant actions of (-)-epigallocatechin-3-gallate.
    Zhang H; Cao D; Cui W; Ji M; Qian X; Zhong L
    Free Radic Biol Med; 2010 Dec; 49(12):2010-8. PubMed ID: 20951799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Up-regulation of thioredoxin and thioredoxin reductase in human malignant pleural mesothelioma.
    Kahlos K; Soini Y; Säily M; Koistinen P; Kakko S; Pääkkö P; Holmgren A; Kinnula VL
    Int J Cancer; 2001 May; 95(3):198-204. PubMed ID: 11307155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity assays of mammalian thioredoxin and thioredoxin reductase: fluorescent disulfide substrates, mechanisms, and use with tissue samples.
    Montano SJ; Lu J; Gustafsson TN; Holmgren A
    Anal Biochem; 2014 Mar; 449():139-46. PubMed ID: 24374250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of thioredoxin and thioredoxin reductase by 4-hydroxy-2-nonenal in vitro and in vivo.
    Fang J; Holmgren A
    J Am Chem Soc; 2006 Feb; 128(6):1879-85. PubMed ID: 16464088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thioredoxin-dependent system. Application of inhibitors.
    Jastrząb A; Skrzydlewska E
    J Enzyme Inhib Med Chem; 2021 Dec; 36(1):362-371. PubMed ID: 33356659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.